AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26811112 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative estrogen therapy among postmenopausal patients with mesh exposure
Number of subjects: 2123
Study 25217457 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 5054
Study 25217457 — intervention group
Group type: COMPARATOR
Intervention: Zotarolimus-eluting stents (ZES-R)
Number of subjects: 5054
Study 22669792 — intervention group
Group type: EXPERIMENTAL
Intervention: Videogame players
Number of subjects: 0
Study 22669792 — intervention group
Group type: COMPARATOR
Intervention: Nonvideogame players
Number of subjects: 0
Study 21069899 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil at an effect-site concentration of 2.0 ng/ml (RF₂(.)₀)
Number of subjects: 90
Study 21069899 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil at an effect-site concentration of 2.5 ng/ml (RF₂(.)₅)
Number of subjects: 90
Study 21069899 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil at an effect-site concentration of 1.5 ng/ml (RF₁(.)₅)
Number of subjects: 90
Study 17707537 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 224
Study 17707537 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy (CMF)
Number of subjects: 224
Study 17707537 — intervention group
Group type: EXPERIMENTAL
Intervention: Low expression of the BRCA1/BRCA2/Rad51 complex
Number of subjects: 224
Study 12676056 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with mild Parkinson's disease
Number of subjects: 3
Study 12676056 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy elderly with mild‐to‐moderate hippocampal atrophy
Number of subjects: 3
Study 12676056 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 3
Study 10877311 — intervention group
Group type: EXPERIMENTAL
Intervention: ZDV+ddC treatment
Number of subjects: 0
Study 10877311 — intervention group
Group type: COMPARATOR
Intervention: ZDV alone
Number of subjects: 0
Study 8623182 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA)
Number of subjects: 127
Study 8623182 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine-Prednisone (Aza-Pred)
Number of subjects: 127
Study 8623182 — intervention group
Group type: COMPARATOR
Intervention: Aza-Pred
Number of subjects: 127
Study 8623182 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA
Number of subjects: 127
Study 8623182 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA and Aza-Pred
Number of subjects: 127
Study 1417189 — intervention group
Group type: EXPERIMENTAL
Intervention: Topically applied recombinant basic fibroblast growth factor (bFGF)
Number of subjects: 0
Study 1417189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6426073 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate 2 mg inhaled from a pressurised metered dose inhaler
Number of subjects: 10
Study 6426073 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate 10 mg inhaled from a pressurised metered dose inhaler
Number of subjects: 10
Study 6426073 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate 20 mg inhaled from a pressurised metered dose inhaler
Number of subjects: 10
Study 6426073 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate 20 mg inhaled from a Spincap
Number of subjects: 10
Study 6426073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30990550 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin mouthwash (25 mg/5 mL water)
Number of subjects: 275
Study 30990550 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine-lidocaine-antacid mouthwash
Number of subjects: 275
Study 30990550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study 30990550 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin mouthwash
Number of subjects: 275
Study 28827196 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (4-hour theoretical training followed by simulations)
Number of subjects: 20
Study 28827196 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (4-hour training first followed by simulations)
Number of subjects: 20
Study 28827196 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 28827196 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1
Number of subjects: 20
Study 28827196 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2
Number of subjects: 20
Study 25811308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport Supplements (SS)
Number of subjects: 11
Study 25811308 — intervention group
Group type: COMPARATOR
Intervention: Fast Food (FF)
Number of subjects: 11
Study 22899427 — intervention group
Group type: EXPERIMENTAL
Intervention: Acquiring New Skills While Enhancing Remaining Strengths (ANSWERS) intervention; 6-curriculum guided sessions with an intervention specialist.
Number of subjects: 0
Study 22899427 — intervention group
Group type: COMPARATOR
Intervention: Control group; no specific intervention details provided.
Number of subjects: 0
Study 21030675 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (oral 2 × 100 mg Confortid daily for 7 days)
Number of subjects: 15
Study 21030675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 19429669 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil 1 microg kg(‐1)
Number of subjects: 42
Study 19429669 — intervention group
Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 42
Study 17303494 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 6-8 hours after mifepristone treatment
Number of subjects: 1080
Study 17303494 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol 24 hours after mifepristone treatment
Number of subjects: 1080
Study 19238647 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% lidocaine spray plus 2% lidocaine jelly lubrication
Number of subjects: 60
Study 19238647 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine jelly lubrication alone
Number of subjects: 60
Study 11081321 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive group
Number of subjects: 63
Study 11081321 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study 9011481 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interferon-alpha2b (10 MU administered subcutaneously daily until normalization of serum transaminase concentrations)
Number of subjects: 24
Study 9011481 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interferon-alpha2b
Number of subjects: 24
Study 1291635 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetostrictive scaler
Number of subjects: 40
Study 1291635 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezoelectric scaler
Number of subjects: 40
Study 1291635 — intervention group
Group type: EXPERIMENTAL
Intervention: Air turbine scaler
Number of subjects: 40
Study 6479057 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive training programme
Number of subjects: 238
Study 6479057 — intervention group
Group type: COMPARATOR
Intervention: Standard training programme
Number of subjects: 238
Study 6479057 — intervention group
Group type: COMPARATOR
Intervention: 14 months post-training assessment
Number of subjects: 238
Study 31434028 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-tobacco flavored e-cigarettes (fruit, menthol)
Number of subjects: 100
Study 31434028 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol flavored e-cigarettes
Number of subjects: 100
Study 31434028 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-containing e-cigarettes (6 mg/mL)
Number of subjects: 100
Study 31434028 — intervention group
Group type: COMPARATOR
Intervention: Nicotine-free e-cigarettes
Number of subjects: 100
Study 29150312 — intervention group
Group type: EXPERIMENTAL
Intervention: Childcare intervention alone (CC)
Number of subjects: 18
Study 29150312 — intervention group
Group type: EXPERIMENTAL
Intervention: Childcare intervention with parental component (CC+HOME)
Number of subjects: 18
Study 29150312 — intervention group
Group type: COMPARATOR
Intervention: Typical curriculum comparison group (COM)
Number of subjects: 18
Study 27019413 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical navigation
Number of subjects: 10
Study 27019413 — intervention group
Group type: COMPARATOR
Intervention: No surgical navigation
Number of subjects: 10
Study 24584988 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT Plus (N=74) - provided evidence-based interventions (psychoeducation, family interventions, individual placement and support, cognitive behavioral therapy)
Number of subjects: 159
Study 24584988 — intervention group
Group type: COMPARATOR
Intervention: Standard ACT (N=85) - provided standard assertive community treatment
Number of subjects: 159
Study 22910929 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy (CR; n = 26)
Number of subjects: 60
Study 22910929 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated tomotherapy (TT; n = 34)
Number of subjects: 60
Study 22910929 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 60
Study 22910929 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms (CR and TT)
Number of subjects: 60
Study 20417565 — intervention group
Group type: EXPERIMENTAL
Intervention: Myoconjunctival PMMA implant
Number of subjects: 150
Study 20417565 — intervention group
Group type: COMPARATOR
Intervention: Traditional PMMA implant
Number of subjects: 150
Study 20417565 — intervention group
Group type: COMPARATOR
Intervention: Porous polyethylene implant
Number of subjects: 150
Study 18826868 — intervention group
Group type: EXPERIMENTAL
Intervention: Trileptal oral suspension (300 mg)
Number of subjects: 19
Study 18826868 — intervention group
Group type: COMPARATOR
Intervention: Film-coated tablet (300 mg)
Number of subjects: 19
Study 15915007 — intervention group
Group type: EXPERIMENTAL
Intervention: formoterol pMDI (12-microg dose)
Number of subjects: 49
Study 15915007 — intervention group
Group type: EXPERIMENTAL
Intervention: formoterol DPI (Aerolizer, 12-microg dose)
Number of subjects: 49
Study 15915007 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 49
Study 12843212 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)Tc-TRODAT-1 SPECT
Number of subjects: 20
Study 12843212 — intervention group
Group type: COMPARATOR
Intervention: (18)F-FDOPA PET
Number of subjects: 20
Study 10382128 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ferrous sulfate and a 2-week course of bismuth subcitrate, amoxicillin, and metronidazole (Group A)
Number of subjects: 43
Study 10382128 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo for iron and a 2-week course of triple therapy (Group B)
Number of subjects: 43
Study 10382128 — intervention group
Group type: COMPARATOR
Intervention: Oral ferrous sulfate and a 2-week course of placebo (Group C)
Number of subjects: 43
Study 9715289 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow oxygen (O2) inhalation
Number of subjects: 32
Study 9715289 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual isosorbide dinitrate (ISDN)
Number of subjects: 32
Study 9715289 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous aminophylline (AMN)
Number of subjects: 32
Study 9715289 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nifedipine (NIF)
Number of subjects: 32
Study 2057244 — intervention group
Group type: EXPERIMENTAL
Intervention: EXOSURF (5 mL/kg intratracheally)
Number of subjects: 178
Study 2057244 — intervention group
Group type: COMPARATOR
Intervention: Control (air 5 mL/kg intratracheally)
Number of subjects: 178
Study 30849345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept monotherapy (IAI) 2 mg every 4 weeks until week 12, then every 8 weeks if no rescue needed; every 4 weeks plus sham/active PDT if rescue criteria met.
Number of subjects: 54
Study 30849345 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal aflibercept plus rescue photodynamic therapy (IAI + rPDT).
Number of subjects: 54
Study 30849345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept monotherapy (IAI)
Number of subjects: 54
Study 30849345 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal aflibercept plus rescue photodynamic therapy (IAI + rPDT)
Number of subjects: 54
Study 28127507 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalfampridine treatment for 12–14 days
Number of subjects: 34
Study 26011140 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin SR 5 mg twice daily in addition to standard of care management
Number of subjects: 54
Study 26011140 — intervention group
Group type: COMPARATOR
Intervention: Standard of care management (daily oral hydration and diclofenac 75 mg IM on demand)
Number of subjects: 54
Study 26011140 — intervention group
Group type: COMPARATOR
Intervention: Control group only
Number of subjects: 54
Study 26011140 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin therapy
Number of subjects: 54
Study 23800222 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinent drinking goal
Number of subjects: 680
Study 23800222 — intervention group
Group type: COMPARATOR
Intervention: Nonabstinent drinking goal
Number of subjects: 680
Study 21826719 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal hypopressive technique (AHT)
Number of subjects: 34
Study 21826719 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of AHT + PFM
Number of subjects: 34
Study 21826719 — intervention group
Group type: EXPERIMENTAL
Intervention: AHT + PFM
Number of subjects: 34
Study 20197168 — intervention group
Group type: EXPERIMENTAL
Intervention: Interceptive orthodontics (IO)
Number of subjects: 170
Study 20197168 — intervention group
Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 170
Study 18254272 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump surgery
Number of subjects: 40
Study 18254272 — intervention group
Group type: COMPARATOR
Intervention: Off-pump surgery
Number of subjects: 40
Study 18254272 — intervention group
Group type: EXPERIMENTAL
Intervention: Both on-pump and off-pump
Number of subjects: 40
Study 18254272 — intervention group
Group type: COMPARATOR
Intervention: On-pump vs Off-pump
Number of subjects: 40
Study 16133853 — intervention group
Group type: EXPERIMENTAL
Intervention: ICE guided cardioversion
Number of subjects: 400
Study 16133853 — intervention group
Group type: COMPARATOR
Intervention: Conventional cardioversion strategy
Number of subjects: 400
Study 12216152 — intervention group
Group type: EXPERIMENTAL
Intervention: CAM walker
Number of subjects: 50
Study 12216152 — intervention group
Group type: COMPARATOR
Intervention: Cast
Number of subjects: 50
Study 9564796 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-mite shampoo
Number of subjects: 85
Study 9564796 — intervention group
Group type: COMPARATOR
Intervention: Placebo shampoo
Number of subjects: 85
Study 9564796 — intervention group
Group type: COMPARATOR
Intervention: Parental control
Number of subjects: 85
Study 9564796 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncarpeted floors and mattress encasements
Number of subjects: 85
Study 7649343 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake in girls
Number of subjects: 35072
Study 7649343 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake in boys
Number of subjects: 35072
Study 7649343 — intervention group
Group type: EXPERIMENTAL
Intervention: Food-frequency questionnaire
Number of subjects: 35072
Study 2764269 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch solution (HD-HES group, n = 15, ratio of replacement 1:1)
Number of subjects: 45
Study 2764269 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer's lactate (HD-RL group, n = 15, ratio 2.5:1)
Number of subjects: 45
Study 2764269 — intervention group
Group type: COMPARATOR
Intervention: No hemodilution (Control group, n = 15)
Number of subjects: 45
Study 1036604 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodoxamic acid (Endomirabil)
Number of subjects: 86
Study 1036604 — intervention group
Group type: COMPARATOR
Intervention: Other intravenous contrast media
Number of subjects: 86
Study 31125470 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg/kg)
Number of subjects: 90
Study 31125470 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.08 mg/kg)
Number of subjects: 90
Study 27913576 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 333
Study 27913576 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 333
Study 27913576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333
Study 26382732 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D status (serum 25-hydroxyvitamin D)
Number of subjects: 782
Study 23449533 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid-free (SF) immunosuppression
Number of subjects: 130
Study 23449533 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid-based (SB) immunosuppression
Number of subjects: 130
Study 23449533 — intervention group
Group type: COMPARATOR
Intervention: Both SF and SB groups
Number of subjects: 130
Study 23449533 — intervention group
Group type: COMPARATOR
Intervention: Presence of de novo antibodies
Number of subjects: 130
Study 21314651 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention including a 6-hour training course and provision of technical aids (hip protectors, sensor mats)
Number of subjects: 333
Study 21314651 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention
Number of subjects: 333
Study 21314651 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 333
Study 19879495 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored messages for monitors
Number of subjects: 531
Study 19879495 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored messages for blunters
Number of subjects: 531
Study 19879495 — intervention group
Group type: COMPARATOR
Intervention: Mismatched messages
Number of subjects: 531
Study 16806710 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser treatment (300 mW, 830 nm)
Number of subjects: 90
Study 16806710 — intervention group
Group type: COMPARATOR
Intervention: Sham laser treatment (placebo)
Number of subjects: 90
Study 16806710 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser treatment
Number of subjects: 90
Study 12800795 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery followed by immunotherapy
Number of subjects: 0
Study 12800795 — intervention group
Group type: COMPARATOR
Intervention: Cytoreductive surgery
Number of subjects: 0
Study 10701280 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional-patient partnership model of discharge planning
Number of subjects: 158
Study 10701280 — intervention group
Group type: COMPARATOR
Intervention: Usual discharge planning
Number of subjects: 158
Study 9199862 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced service
Number of subjects: 111
Study 9199862 — intervention group
Group type: COMPARATOR
Intervention: Usual service
Number of subjects: 111
Study 8468720 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interleukin-2 plus lymphokine-activated killer (LAK) cells
Number of subjects: 181
Study 8468720 — intervention group
Group type: COMPARATOR
Intervention: High-dose interleukin-2 alone
Number of subjects: 181
Study 8468720 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interleukin-2 plus LAK cells
Number of subjects: 181
Study 8468720 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose interleukin-2 plus LAK cells (melanoma subgroup)
Number of subjects: 181
Study 8468720 — intervention group
Group type: COMPARATOR
Intervention: High-dose interleukin-2 alone (melanoma subgroup)
Number of subjects: 181
Study 2419524 — intervention group
Group type: EXPERIMENTAL
Intervention: PVB (cisplatin, vinblastine, and bleomycin)
Number of subjects: 180
Study 2419524 — intervention group
Group type: COMPARATOR
Intervention: PVB plus doxorubicin
Number of subjects: 180
Study 2419524 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance vinblastine
Number of subjects: 180
Study 2419524 — intervention group
Group type: EXPERIMENTAL
Intervention: PVB
Number of subjects: 180
Study 29529160 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 1609
Study 29529160 — intervention group
Group type: COMPARATOR
Intervention: Corn-soy blends (CSB)
Number of subjects: 1609
Study 26840358 — intervention group
Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 120
Study 26840358 — intervention group
Group type: COMPARATOR
Intervention: Magnesium
Number of subjects: 120
Study 26840358 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 120
Study 24886119 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention (childcare center intervention, family intervention, community intervention)
Number of subjects: 357
Study 24886119 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 357
Study 24886119 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 357
Study 23030580 — intervention group
Group type: EXPERIMENTAL
Intervention: Low health literacy
Number of subjects: 703
Study 23030580 — intervention group
Group type: COMPARATOR
Intervention: Adequate health literacy
Number of subjects: 703
Study 20033227 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrojejunostomy (GJJ)
Number of subjects: 39
Study 20033227 — intervention group
Group type: COMPARATOR
Intervention: Stent placement
Number of subjects: 39
Study 18312323 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 140
Study 18312323 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 140
Study 15688235 — intervention group
Group type: EXPERIMENTAL
Intervention: Polidocanol (5 mg/ml)
Number of subjects: 20
Study 15688235 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine hydro‐chloride (5 mg/ml) + Adrenaline (5 microg/ml)
Number of subjects: 20
Study 12231524 — intervention group
Group type: EXPERIMENTAL
Intervention: N-(4-Hydroxyphenyl)retinamide and tamoxifen
Number of subjects: 36
Study 12231524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 10201419 — intervention group
Group type: EXPERIMENTAL
Intervention: National Adult Reading Test (NART)
Number of subjects: 25
Study 10201419 — intervention group
Group type: EXPERIMENTAL
Intervention: Cambridge Contextual Reading Test (CCRT)
Number of subjects: 25